Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance.
- NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_assertion description "[HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance.
- NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_assertion evidence source_evidence_literature NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance.
- NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_assertion SIO_000772 25708529 NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance.
- NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_assertion wasDerivedFrom befree-2016 NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance.
- NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_assertion wasGeneratedBy ECO_0000203 NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1265849.RAtdB4FyZrXdtyo-Htx5f-zY_YucuTJ2Xg1rxsRQ0tVuQ130_provenance.